Nexturax logo

Nexturax

Information Technology & Software Development

Building Smarter Digital Products for a Growing World

Nexturax is a Jaffna-based software and digital solutions company helping businesses turn ideas into scalable web, mobile, AI, and cloud-powered products.

About

Nexturax is a software and digital product development company based in Jaffna, Sri Lanka, helping businesses and organizations transform ideas into reliable, scalable, and future-ready digital solutions.

We specialize in custom software development, web and mobile applications, AI-powered solutions, SaaS and product development, backend systems, cloud infrastructure, DevOps, and digital growth. Our team combines modern engineering practices with a practical, business-focused approach to build technology that solves real-world problems and creates measurable value.

From startups and growing businesses to established organizations, we work closely with our clients throughout the entire product journey — from discovery and architecture to design, development, deployment, and ongoing support. Our technology expertise includes modern platforms and frameworks such as Next.js, React, .NET, Node.js, PHP, Flutter, Python, PostgreSQL, AWS, Azure, Docker, and Kubernetes.

Our portfolio spans multiple sectors, including education, healthcare, logistics, hospitality, transportation, and business services. We have built e-learning platforms, AI-powered learning systems, veterinary management platforms, delivery solutions, booking platforms, and other custom business applications.

Founded in 2023 in Jaffna, Nexturax is committed to contributing to Sri Lanka's growing technology ecosystem while delivering world-class software solutions to clients locally and internationally. Our mission is simple: **empower growing businesses with smarter technology that helps them innovate, scale, and succeed.**

Products and Services

What Nexturax offers to customers and partners.

No products listed yet.
Updates

Latest announcements, launches, and opportunities from Nexturax.

No updates yet.